ANORO is not indicated for the treatment of asthma. use of a long-acting beta 2-adrenergic agonist (LABA), including vilanterol, one of the active ingredients in ANORO, without an inhaled corticosteroid (ICS), in patients with asthma.patients with severe hypersensitivity to milk proteins or who have demonstrated hypersensitivity to umeclidinium, vilanterol, or any of the excipients.
